Mark McLean
Impact in
- Hepatology top 10%
- Hepatitis C virus research
- Anesthesiology and Pain Medicine top 10%
- Pain Management and Opioid Use
Papers in
-
- Opioid Use Disorder Treatment 6
-
- Pharmaceutical Practices and Patient Outcomes 2
- Co-authors
- Seonaid Nolan (6 shared papers)Annabel Mead (8 shared papers)Keith Ahamad (6 shared papers)Evan Wood (5 shared papers)Ján Klimas (3 shared papers)Mark Viljoen (5 shared papers)Milan Khara (5 shared papers)Jesse D. Raffa (5 shared papers)
In The Last Decade
Mark McLean
19 papers receiving 367 citations
Peers
Comparison fields: 5 of 45
- Hepatology 67
- Anesthesiology and Pain Medicine 27
- Neurology 75
- Toxicology 17
- Public Health, Environmental and Occupational Health 109
Countries citing papers authored by Mark McLean
This map shows the geographic impact of Mark McLean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark McLean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark McLean more than expected).
Fields of papers citing papers by Mark McLean
This network shows the impact of papers produced by Mark McLean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark McLean. The network helps show where Mark McLean may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark McLean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 77 | |
| 2 | 2007 | 67 | |
| 3 | 2007 | 55 | |
| 4 | 2017 | 24 | |
| 5 | 2019 | 24 | |
| 6 | 2017 | 21 | |
| 7 | 2019 | 20 | |
| 8 | 2020 | 18 | |
| 9 | 2023 | 18 | |
| 10 | 2007 | 11 | |
| 11 | 2022 | 8 | |
| 12 | 2008 | 8 | |
| 13 | 2023 | 7 | |
| 14 | 2019 | 6 | |
| 15 | 2021 | 5 | |
| 16 | 2007 | 3 | |
| 17 | 2003 | 3 | |
| 18 | Drug overdose: prevention and response. Guidance for helplines. | 2004 | 2 |
| 19 | 2016 | 1 |
About Mark McLean
Mark McLean is a scholar working on Public Health, Environmental and Occupational Health, Geriatrics and Gerontology, Toxicology, Anesthesiology and Pain Medicine and Infectious Diseases, having authored 19 papers that have together received 378 indexed citations. Recurring topics across this work include Opioid Use Disorder Treatment (6 papers), HIV/AIDS drug development and treatment (3 papers), Forensic Toxicology and Drug Analysis (2 papers), Pain Management and Opioid Use (2 papers), Substance Abuse Treatment and Outcomes (2 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Cannabis and Cannabinoid Research (1 paper) and HIV/AIDS Research and Interventions (1 paper). The work is most often cited by research in Hepatology (67 citations), Anesthesiology and Pain Medicine (27 citations), Neurology (75 citations), Toxicology (17 citations) and Public Health, Environmental and Occupational Health (109 citations). Mark McLean has collaborated with scholars based in Canada, Australia and Ireland. Frequent co-authors include Seonaid Nolan, Annabel Mead, Keith Ahamad, Evan Wood, Ján Klimas, Mark Viljoen, Milan Khara, Jesse D. Raffa, Jason Grebely and Fiona Duncan. Their work appears in journals such as Journal of Addiction Medicine, Substance Abuse, Journal of Gastroenterology and Hepatology, Canadian Journal of Public Health and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.